Xenon Pharmaceuticals adopts Executive Incentive Plan; sets 2023 salaries and 2022 bonuses for executives

Xenon Pharmaceuticals Inc.

CEO Ian Mortimer: 2022 non-equity bonus $343,422; 2023 base salary $665,000.
CFO Sherry Aulin: 2022 bonus $178,619; 2023 base salary $465,000.
CMO Christopher Kenney: 2022 bonus $195,300; 2023 base salary $510,000.
CEO eligible for up to 60% base salary under new plan; CFO and CMO eligible for up to 40%.
Incentive Compensation Plan allows cash awards based on corporate goals (R&D, regulatory, financial milestones).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.